Get started
Author

Gregory J. Hooper

Observed names: G Hooper, G. Hooper, G. J. HOOPER, Greg J. Hooper, Gregory Hooper, Hooper, Gregory
OpenAlex ID: A5027340010
Carmabins A and B, New Lipopeptides from the Caribbean Cyanobacterium Lyngbya majuscula
1998 · Gregory J. Hooper, Jimmy Orjala, et al. · Journal of Natural Products · 84
New alkaloids from a South African latrunculid sponge
1996 · Gregory J. Hooper, Michael T. Davies-Coleman, et al. · Tetrahedron Letters · 70
Maintenance erlotinib versus erlotinib at disease progression in patients with advanced non-small-cell lung cancer who have not progressed following platinum-based chemotherapy (IUNO study)
2016 · Saulius Cicènas, Sarayut Lucien Geater, et al. · Lung Cancer · 61
PDF
Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies
2018 · Yi-Long Wu, Victor Lee, et al. · Lung Cancer · 48
Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv600 mutation–positive melanoma receiving adjuvant vemurafenib
2020 · P.A. Ascierto, K.D. Lewis, et al. · Annals of Oncology · 47
New Metabolites from the South African soft coral Capnella thyrsoidea
1995 · Gregory J. Hooper, Michael T. Davies-Coleman · Tetrahedron · 44
Sesquiterpene hydroquinones from the South African soft coral Alcyonium fauri
1995 · Gregory J. Hooper, Michael T. Davies-Coleman · Tetrahedron Letters · 32
A phase Ib study to assess the efficacy and safety of vismodegib in combination with ruxolitinib in patients with intermediate- or high-risk myelofibrosis
2018 · Stephen Couban, Giulia Benevolo, et al. · Journal of Hematology & Oncology · 30
PDF
Immunotherapy Bridge 2017 and Melanoma Bridge 2017: meeting abstracts
2018 · David Carbone, Michael Sharpnack, et al. · Journal of Translational Medicine · 28
PDF
Randomized Controlled Trial of Danoprevir Plus Peginterferon Alfa-2a and Ribavirin in Treatment-Naïve Patients With Hepatitis C Virus Genotype 1 Infection
2013 · Patrick Marcellin, Curtis Cooper, et al. · Gastroenterology · 27
Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirin
2014 · Jordan J. Feld, Ira M. Jacobson, et al. · Journal of Hepatology · 21
New Diterpenes from the South African Soft Coral Eleutherobia aurea
1997 · Gregory J. Hooper, Michael T. Davies-Coleman, et al. · Journal of Natural Products · 21
Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon α‐2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) for 16 or 24 weeks
2009 · Maribel Rodriguez‐Torres, Sugantha Govindarajan, et al. · Liver International · 15
New Antimicrobial C14and C13Amines from a South African Marine Ascidian
1995 · Gregory J. Hooper, Michael T. Davies-coleman, et al. · Natural product letters · 13
Two-Year Outcomes Following Delandistrogene Moxeparvovec Treatment in Ambulatory Patients with Duchenne Muscular Dystrophy: Phase 3 EMBARK Trial
2026 · Jerry R. Mendell, Francesco Muntoni, et al. · Neurology and Therapy · 9
PDF
Patient privacy issues in a renal dialysis unit.
1995 · G Hooper · PubMed · 5
797 Easy to Assess On-treatment Parameters Correlate With Degree of Virological Response After 12 Weeks of Treatment
2008 · D. Jensen, B. Freilich, et al. · Journal of Hepatology · 2
The Roche HD natural history study – An external comparator by design
2019 · G. Hooper, G. Palermo, et al. · Journal of the Neurological Sciences · 1
PDF
A safety, tolerability and biomarker update from an ongoing open-label extension study of RG6042 in adults with early manifest Huntington’s disease
2019 · B. Leavitt, S. Tabrizi, et al. · Journal of the Neurological Sciences · 1
PDF
Biologically active natural products from South African marine invertebrates
1997 · Gregory Hooper · 1
F24 Design of a prospective, longitudinal, natural history study in huntington’s disease
2018 · Gregory Hooper, Dylan Trundell, et al. · Journal of Neurology Neurosurgery & Psychiatry
463P Real-world treatment patterns for advanced EGFR wild-type NSCLC in second or third line in a large US database
2016 · Y. Li, T. Pattipaka, et al. · Annals of Oncology
649 Long-Term Durability of Sustained Viral Response (SVR) in Children Treated for Chronic Hepatitis C (Peds C Trial)
2014 · Kathleen Schwarz, Jean P. Molleston, et al. · Gastroenterology
P.285 Differences in virus and host characteristics between patients with HCV genotype 2 or 3 participating in a large international study
2006 · S. Zeuzem, S. Pappas, et al. · Journal of Clinical Virology
Linezolid Is Well-Tolerated in Ventilator–Associated Pneumoni
2003 · Greg J. Hooper, Rodney V. Croos-Dabrera, et al. · CHEST Journal
Works count: 28
Citation count: 560
H-index: 13
I10-index: 14
Year
Topic
Type